title: The role of somatostatin analogs in the management of immunoproliferative disease.
authors.affiliation: Department of Endocrinological and Metabolic Sciences, University of Genova, Italy. ferone@unige.it
authors.forename: D
authors.initials: D
authors.lastname: Ferone
authors.forename: M
authors.initials: M
authors.lastname: Arvigo
authors.forename: C
authors.initials: C
authors.lastname: Semino
authors.forename: R
authors.initials: R
authors.lastname: Pivonello
authors.forename: P M
authors.initials: PM
authors.lastname: van Hagen
authors.forename: A
authors.initials: A
authors.lastname: Barreca
authors.forename: F
authors.initials: F
authors.lastname: Minuto
mesh_terms: D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D007160:Immunoproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D008214:Lymphocytes / Q000378:metabolism*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D019275:Radiopharmaceuticals; D051381:Rats; D017481:Receptors, Somatostatin / Q000378:metabolism*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014018:Tissue Distribution
chemical_list: D018931:Antineoplastic Agents, Hormonal; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin; D013004:Somatostatin